BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36870097)

  • 21. Clinical outcome of pelvic exenteration in patients with advanced or recurrent uterine cervical cancer.
    Tanaka S; Nagase S; Kaiho-Sakuma M; Nagai T; Kurosawa H; Toyoshima M; Tokunaga H; Otsuki T; Utsunomiya H; Takano T; Niikura H; Ito K; Yaegashi N
    Int J Clin Oncol; 2014 Feb; 19(1):133-8. PubMed ID: 23404487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.
    Berek JS; Howe C; Lagasse LD; Hacker NF
    Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extended pelvic resections for recurrent uterine and cervical cancer: out-of-the-box surgery.
    Caceres A; Mourton SM; Bochner BH; Gerst SR; Liu L; Alektiar KM; Kardos SV; Barakat RR; Boland PJ; Chi DS
    Int J Gynecol Cancer; 2008; 18(5):1139-44. PubMed ID: 18053063
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.
    Bizzarri N; Chiantera V; Ercoli A; Fagotti A; Tortorella L; Conte C; Cappuccio S; Di Donna MC; Gallotta V; Scambia G; Vizzielli G
    J Minim Invasive Gynecol; 2019; 26(7):1316-1326. PubMed ID: 30611973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.
    Kanao H; Aoki Y; Hisa T; Takeshima N
    Gynecol Oncol; 2017 Aug; 146(2):438-439. PubMed ID: 28576262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients.
    Chiantera V; Rossi M; De Iaco P; Koehler C; Marnitz S; Ferrandina G; Legge F; Parazzini F; Scambia G; Schneider A; Vercellino GF
    Int J Gynecol Cancer; 2014 Jun; 24(5):916-22. PubMed ID: 24442006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Minimally invasive versus open pelvic exenteration in gynecological malignancies: a propensity-matched survival analysis.
    Bizzarri N; Chiantera V; Loverro M; Sozzi G; Perrone E; Gueli Alletti S; Costantini B; Gallotta V; Tortorella L; Fagotti A; Fanfani F; Ercoli A; Scambia G; Vizzielli G
    Int J Gynecol Cancer; 2023 Feb; 33(2):190-197. PubMed ID: 36593063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies.
    Andikyan V; Khoury-Collado F; Sandadi S; Tew WP; O'Cearbhaill RE; Konner JA; Sonoda Y; Barakat RR; Chi DS; Abu-Rustum NR
    Int J Gynecol Cancer; 2013 Jun; 23(5):923-8. PubMed ID: 23698798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
    Matsuo K; Mandelbaum RS; Adams CL; Roman LD; Wright JD
    Gynecol Oncol; 2019 May; 153(2):368-375. PubMed ID: 30792003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pelvic exenteration for primary and recurrent gynaecological malignancies.
    de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
    Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
    Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
    Oranratanaphan S; Termrungruanglert W; Sirisabya N
    Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Utilization and perioperative outcome of minimally invasive pelvic exenteration in gynecologic malignancies: A national study in the United States.
    Matsuo K; Matsuzaki S; Mandelbaum RS; Kanao H; Chang EJ; Klar M; Roman LD; Wright JD
    Gynecol Oncol; 2021 Apr; 161(1):39-45. PubMed ID: 33402282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
    Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
    Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
    Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
    Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
    Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
    Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
    Williams M; Perera M; Nouhaud FX; Coughlin G
    Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended pelvic resection for gynecological malignancies: A review of out-of-the-box surgery.
    Daix M; Martinez Gomez C; Angeles MA; Tock S; Gladieff L; Gabiache E; Mery E; Martinez A; Cibula D; Ferron G
    Gynecol Oncol; 2022 May; 165(2):393-400. PubMed ID: 35331571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short- and long-term outcomes following pelvic exenteration for gynae-oncological and colorectal cancers: A 9 year consecutive single-centre cohort study.
    Katory M; McLean R; Paez E; Kucukmetin A; Naik R
    Int J Surg; 2017 Jul; 43():38-45. PubMed ID: 28529192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.
    Andikyan V; Khoury-Collado F; Gerst SR; Talukdar S; Bochner BH; Sandhu JS; Abu-Rustum N; Sonoda Y; Barakat RR; Chi DS
    Gynecol Oncol; 2012 Sep; 126(3):346-50. PubMed ID: 22555107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.